PatientsLikeMe ™

ALS
Skip over navigation
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Neurodex

What is Quinidine/dextromethorphan? Neurodex is a combination of 30mg Dextromethorphan (found in cough medicine) and 30mg Quinidine made by Avanir Phamaceuticals. In a randomised, multicentre control trial the combination of these two agents was found to halve episodes of emotional lability relative to either agent alone. Read more...Click to read more below

Avanir's Quinidine/dextromethorphan site


Reasons Taken

12 patients in the community are taking or have taken Quinidine/dextromethorphan.

Reason # Patients Percentage of patients
Emotional lability 10 83%
Cramps 1 8%
disease-related symptoms 1 8%

Dosages

Based on the patients currently taking Quinidine/dextromethorphan.

  0 mg Daily 40 mg Daily 50 mg Daily 60 mg Daily 90 mg Daily 105 mg Daily
  4 Number of Patients: 4 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Quinidine/dextromethorphan or how long patients were taking Quinidine/dextromethorphan before stopping.

Currently taking Quinidine/dextromethorphan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
1
2
3

Stopped taking Quinidine/dextromethorphan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
1
1
Why Patients Stopped Taking Quinidine/dextromethorphan (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense 1 50% Expense: 50%
Course of treatment ended 1 50% Course of treatment ended: 50%

Patient Reported Evaluations

Results from 1 patient evaluation. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Moderate 100% 1

Emotional lability

Side-effects (as an overall problem)

Severe 0% 0
Moderate 0% 0
Mild 0% 0
None 100% 1

Top reported side-effects include:

Summary results are based on 1 individual response. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 1)

  • ALS Boy
    Sex: M
    Mouth/throat: mild
    Arms: moderate
    Chest: none
    Legs: moderate
    See profile
  • ALS Boy
  • by ALS Boy
    Oct 20, 2008
  • EfficacyModerate
  • Side-effectsNone
  • Emotional lability

See all evaluation results for Quinidine/dextromethorphan



Back to top